+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032- Product Image
Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032- Product Image
New

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127154
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Radiopharmaceuticals in Nuclear Medicine Market is reshaping clinical pathways by delivering advanced applications in precision diagnostics and targeted therapies. This industry is driving new standards for healthcare outcomes, while simultaneously presenting operational complexities related to manufacturing scale, supply chain agility, and regulatory adherence.

Market Snapshot: Radiopharmaceuticals in Nuclear Medicine Market

The Radiopharmaceuticals in Nuclear Medicine Market advanced from USD 9.78 billion in 2025 to USD 10.69 billion in 2026 and is projected to reach USD 19.52 billion by 2032, reflecting a CAGR of 10.37%. This steady growth signals a wider shift as radiopharmaceuticals extend beyond niche diagnostics into core components of comprehensive cancer care, clinical imaging, and contemporary therapeutic interventions. The evolution toward integrated theranostic solutions and the rising adoption of radioligand therapies are key drivers for healthcare adoption. However, expanding market reach requires responses to increasingly sophisticated logistics, the need for scalable manufacturing, and handling evolving regulatory frameworks.

Scope & Segmentation

This report systematically analyzes the driving dimensions of the radiopharmaceuticals sector:

  • Product Types: Insights into diagnostic radiopharmaceuticals for routine nuclear imaging, and the emergence of therapeutic radioligands that are refocusing multidiscipline clinical care.
  • Isotope Properties: Coverage of radionuclide half-life, emission profiles, required handling protocols, and the effect on clinical workflow—including growing relevance of alpha and beta emitters.
  • Clinical Application Areas: Evaluation of cancer, cardiology, and neurology indications, with emphasis on how technical innovation is accelerating adoption in major disease management pathways.
  • End-User Readiness: Examination of adoption maturity among hospitals, cancer centers, and independent imaging facilities, highlighting operational and resource-based challenges.
  • Regional Dynamics: Regional perspectives for the Americas, Europe, Middle East & Africa, and Asia-Pacific, with a focus on infrastructure for isotope production, local provider capabilities, and differing reimbursement strategies.
  • Technological Ecosystem: Overview of advanced manufacturing processes, automation trends, facility compliance, and innovations in distribution networks.

Key Takeaways for Senior Decision-Makers

  • The rise of theranostics is aligning diagnostics with immediate therapy guidance, fostering demand for coordinated clinical workflows and collaboration across specialties.
  • Manufacturing industrialization and standardized logistics are central to delivering time-sensitive isotopes reliably and at scale, requiring investment in process innovation and networked supply solutions.
  • Flexible supplier relationships and adoption of platform business models are being prioritized to support resilience amid shifting procurement landscapes and changing regulatory expectations.
  • Market access and adoption are driven by the alignment of isotope characteristics, facility resources, and region-specific reimbursement, necessitating tailored commercial approaches.
  • Strategic collaborations with contract development and manufacturing organizations, radiopharmacies, or hospital networks optimize value-chain efficiency, as no single entity covers every requirement in radiopharmaceutical delivery.
  • Clinical evidence supporting improved patient outcomes and seamless workflow integration has become essential in achieving payer acceptance and consistent provider adoption.

Tariff Impact on Radiopharmaceuticals Supply Chain

In 2025, U.S. tariff actions are set to influence radiopharmaceutical manufacturers by increasing procurement complexity and raising costs for critical components, including shielding systems, synthesizers, and purified chemicals. These challenges may cause delays in delivery and higher operational costs, requiring organizations to diversify suppliers, engage in dual-sourcing, and intensify supplier qualification processes. Such strategies, while offering risk mitigation, add burden to companies operating under stringent GMP requirements. Market participants with streamlined, regionally based production models and agile networks will be best positioned to address potential disruptions and uncertainty stemming from regulatory or policy changes.

Methodology & Data Sources

This research applies a triangulated methodology, integrating value-chain mapping, primary interviews with industry leaders and practitioners, and comprehensive reviews of regulatory literature. This rigorous approach underpins the reliability and operational relevance of the insights presented.

Why This Report Matters

  • Enables senior executives to strengthen supply chains, foster evidence-based reimbursement decisions, and accelerate adoption of radiopharmaceutical innovations.
  • Identifies strategic differentiators, such as vertical integration, decentralized production, and frameworks that enhance clinical capabilities and market access.
  • Provides actionable support to guide decision-making for market entry, organizational expansion, or new partnership formation in evolving and regulated environments.

Conclusion

Leadership advantage in the radiopharmaceutical market relies on harmonizing innovation with operational robustness. Aligning investments, partnerships, and clinical workflows supports efficient, scalable, and reliable service in a sector characterized by rapid transformation and regional variation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Radiopharmaceuticals in Nuclear Medicine Market, by Product Type
8.1. Diagnostic Radiopharmaceuticals
8.1.1. PET
8.1.1.1. Fluorine-18 Radiopharmaceuticals
8.1.1.2. Gallium-68 Radiopharmaceuticals
8.1.2. SPECT
8.1.2.1. Iodine-123 Radiopharmaceuticals
8.1.2.2. Technetium-99m Radiopharmaceuticals
8.2. Therapeutic Radiopharmaceuticals
8.2.1. Alpha Emitter
8.2.1.1. Actinium-225
8.2.1.2. Radium-223
8.2.2. Beta Emitter
8.2.2.1. Iodine-131
8.2.2.2. Lutetium-177
8.2.2.3. Yttrium-90
9. Radiopharmaceuticals in Nuclear Medicine Market, by Radionuclide
9.1. Fluorine-18
9.2. Iodine-131
9.3. Lutetium-177
9.4. Technetium-99m
9.5. Yttrium-90
10. Radiopharmaceuticals in Nuclear Medicine Market, by End User
10.1. Academic & Research Institutes
10.2. Hospitals & Clinics
10.2.1. Private Clinics
10.2.2. Public Hospitals
10.3. Imaging Centers
10.3.1. Diagnostic Imaging Centers
10.3.2. Specialty Therapy Centers
11. Radiopharmaceuticals in Nuclear Medicine Market, by Application
11.1. Brain Imaging
11.1.1. PET Brain Agents
11.1.2. SPECT Brain Agents
11.2. Cardiology
11.2.1. Perfusion Imaging
11.2.2. Viability Imaging
11.3. Oncology
11.3.1. PET Imaging
11.3.1.1. Fluorine-18 Radiopharmaceuticals
11.3.1.2. Technetium-99m Radiopharmaceuticals
11.3.2. Therapy
11.3.2.1. Alpha Emitter Therapy
11.3.2.2. Beta Emitter Therapy
12. Radiopharmaceuticals in Nuclear Medicine Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Radiopharmaceuticals in Nuclear Medicine Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Radiopharmaceuticals in Nuclear Medicine Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Radiopharmaceuticals in Nuclear Medicine Market
16. China Radiopharmaceuticals in Nuclear Medicine Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Actinium Pharmaceuticals, Inc.
17.6. AstraZeneca plc
17.7. Bayer AG
17.8. Bracco Imaging S.p.A.
17.9. BWXT Medical Ltd.
17.10. Cardinal Health, Inc.
17.11. Clarity Pharmaceuticals Pty Ltd
17.12. Curium Pharma SAS
17.13. Eckert & Ziegler Strahlen- und Medizintechnik AG
17.14. Eli Lilly and Company
17.15. GE HealthCare, Inc.
17.16. ITM Isotope Technologies Munich SE
17.17. Jubilant Pharmova Limited
17.18. Lantheus Holdings, Inc.
17.19. NorthStar Medical Radioisotopes LLC
17.20. Novartis AG
17.21. PharmaLogic Holdings Corp.
17.22. RayzeBio, Inc.
17.23. Siemens Healthineers AG
17.24. Telix Pharmaceuticals Limited
List of Figures
FIGURE 1. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY GALLIUM-68 RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY GALLIUM-68 RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY GALLIUM-68 RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-123 RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-123 RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-123 RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACTINIUM-225, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACTINIUM-225, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIUM-223, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIUM-223, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECIALTY THERAPY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECIALTY THERAPY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECIALTY THERAPY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET BRAIN AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET BRAIN AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET BRAIN AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT BRAIN AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT BRAIN AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT BRAIN AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
TABLE 193. LATIN AMERICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2032 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2032 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 212. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 215. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 216. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 217. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 218. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2032 (USD MILLION)
TABLE 219. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2032 (USD MILLION)
TABLE 220. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2032 (USD MILLION)
TABLE 221. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 223. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2032 (USD MILLION)
TABLE 224. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2032 (USD MILLION)
TABLE 226. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 227. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 228. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
TABLE 229. EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2032 (USD MILLION)
TABLE 238. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2032 (USD MILLION)
TABLE 239. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 241. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2032 (USD MILLION)
TABLE 242. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2032 (USD MILLION)
TABLE 244. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 245. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 246. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
TABLE 247. MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 248. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 250. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 251. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
TABLE 252. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2032 (USD MILLION)
TABLE 253. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 254. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2032 (USD MILLION)
TABLE 255. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2032 (USD MILLION)
TABLE 256. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2032 (USD MILLION)
TABLE 257. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 259. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2032 (USD MILLION)
TABLE 260. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2032 (USD MILLION)
TABLE 262. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 263. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 264. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
TABLE 265. AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC RADIOPHARMACEUTICALS IN NUCLEAR MEDICIN

Companies Mentioned

The key companies profiled in this Radiopharmaceuticals in Nuclear Medicine market report include:
  • Actinium Pharmaceuticals, Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bracco Imaging S.p.A.
  • BWXT Medical Ltd.
  • Cardinal Health, Inc.
  • Clarity Pharmaceuticals Pty Ltd
  • Curium Pharma SAS
  • Eckert & Ziegler Strahlen- und Medizintechnik AG
  • Eli Lilly and Company
  • GE HealthCare, Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Pharmova Limited
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes LLC
  • Novartis AG
  • PharmaLogic Holdings Corp.
  • RayzeBio, Inc.
  • Siemens Healthineers AG
  • Telix Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.69 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.52 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Radiopharmaceutical for Nuclear Medicine Market - Global Forecast 2025-2030 - Product Image

Radiopharmaceutical for Nuclear Medicine Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • 307 Pages
  • Global
From
Nuclear Medicine Market Report and Forecast 2025-2034 - Product Image

Nuclear Medicine Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Radiopharmaceuticals - Global Strategic Business Report - Product Image

Radiopharmaceuticals - Global Strategic Business Report

  • Report
  • 486 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.